Advertisement
ALGN vs GKOS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and GKOS is a Buy.
Momentum Indicator for ALGN turns positive, indicating new upward trend
ALGN saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In 61 of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 29 of 41 cases over the following month. The odds of a continued upward trend are 71%.
ALGN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALGN crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 55%.
Following a +9.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 187 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 153 of 206 cases where ALGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
ALGN broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. ALGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.786) is normal, around the industry mean (4.964). P/E Ratio (28.769) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
GKOS in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026
The 10-day moving average for GKOS crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
GKOS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in 248 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 252 of 314 cases where GKOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Bearish Trend Analysis
The 10-day RSI Indicator for GKOS moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 32 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
GKOS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.395) is normal, around the industry mean (4.142). P/E Ratio (-68.627) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (12.570) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (15.456) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ALGN | GKOS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 16 | |
SMR RATING 1..100 | 69 | 96 | |
PRICE GROWTH RATING 1..100 | 19 | 34 | |
P/E GROWTH RATING 1..100 | 35 | 88 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALGN's Valuation (63) in the Medical Specialties industry is in the same range as GKOS (87). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.
GKOS's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for ALGN (100). This means that GKOS’s stock grew significantly faster than ALGN’s over the last 12 months.
ALGN's SMR Rating (69) in the Medical Specialties industry is in the same range as GKOS (96). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.
ALGN's Price Growth Rating (19) in the Medical Specialties industry is in the same range as GKOS (34). This means that ALGN’s stock grew similarly to GKOS’s over the last 12 months.
ALGN's P/E Growth Rating (35) in the Medical Specialties industry is somewhat better than the same rating for GKOS (88). This means that ALGN’s stock grew somewhat faster than GKOS’s over the last 12 months.
| ALGN | GKOS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 76% | N/A |
| MACD ODDS (%) | 3 days ago 71% | N/A |
| TrendWeek ODDS (%) | 2 days ago 73% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 78% |
| Advances ODDS (%) | 3 days ago 70% | 3 days ago 78% |
| Declines ODDS (%) | 16 days ago 76% | 27 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 72% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 1 FA rating(s) are green while GKOS’s FA Score has 1 green FA rating(s).
- ALGN’s FA Score: 1 green, 4 red.
- GKOS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 6 TA indicator(s) are bullish while GKOS’s TA Score has 4 bullish TA indicator(s).
- ALGN’s TA Score: 6 bullish, 4 bearish.
- GKOS’s TA Score: 4 bullish, 4 bearish.
Price Growth
ALGN (@Pharmaceuticals: Other) experienced а +14.96% price change this week, while GKOS (@Medical/Nursing Services) price change was +1.35% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
ALGN is expected to report earnings on Feb 03, 2027.
GKOS is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ALGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To ALGN | 1D Price Change % | ||
|---|---|---|---|---|
| ALGN | 100% | N/A | ||
| NVST - ALGN | 71% Closely correlated | -0.50% | ||
| XRAY - ALGN | 59% Loosely correlated | +1.68% | ||
| ICUI - ALGN | 54% Loosely correlated | +1.82% | ||
| LUNG - ALGN | 52% Loosely correlated | N/A | ||
| SOLV - ALGN | 50% Loosely correlated | -0.39% | ||
More | ||||
GKOS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
|---|---|---|---|---|
| GKOS | 100% | -1.07% | ||
| ISRG - GKOS | 51% Loosely correlated | -2.28% | ||
| NTRA - GKOS | 48% Loosely correlated | -2.62% | ||
| RDNT - GKOS | 48% Loosely correlated | -0.56% | ||
| TWST - GKOS | 46% Loosely correlated | -2.37% | ||
| ALGN - GKOS | 43% Loosely correlated | N/A | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| AR.X | 3.245752 | 0.049699 | +1.55% |
| Arweave cryptocurrency | |||
| FEAC | 32.15 | -0.07 | -0.23% |
| Fidelity Enhanced U.S. All-Cap Equity ETF | |||
| BICO.X | 0.013341 | -0.000091 | -0.67% |
| Biconomy cryptocurrency | |||
| REN.X | 0.001913 | -0.000093 | -4.65% |
| Ren cryptocurrency | |||
| DATA.X | 0.099467 | -0.004947 | -4.74% |
| Data Network cryptocurrency | |||